Zenda Woodman1, Carolyn Williamson. 1. Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Observatory 7925, South Africa.
Abstract
PURPOSE OF REVIEW: To provide an update on the origin of the HIV epidemic and insights into how the immune response is shaping virus evolution. RECENT FINDINGS: Characterization of archival samples showed that by the 1960s, HIV had already diverged within humans. It is now estimated that HIV has been in humans since at least the early 1900s. However, despite the potential for different divergent viruses to spread, surprisingly few viruses successfully expanded to cause the global epidemic. In approximately 80% of cases, productive infection is the result of infection with only a single virus or single virus-infected cell. After transmission, HIV evolves at a rapid rate driven by the immune pressure until the virus reaches a delicate survival balance: on one hand avoiding elimination through the development of cytotoxic T-cell immune escape mutations, and on the other sacrificing replication fitness as these mutations may come with a severe fitness cost to the virus. People infected with these 'attenuated' cytotoxic T-cell escape viruses can have a survival advantage. Cytotoxic T-cell responses are molding HIV diversity at a population level resulting in a loss of some of the common immune epitopes. SUMMARY: Insights into the origin of HIV and its evolution between populations and within individuals is essential to understanding HIV pathogenesis and imperative for the design of effective biomedical interventions such as vaccines.
PURPOSE OF REVIEW: To provide an update on the origin of the HIV epidemic and insights into how the immune response is shaping virus evolution. RECENT FINDINGS: Characterization of archival samples showed that by the 1960s, HIV had already diverged within humans. It is now estimated that HIV has been in humans since at least the early 1900s. However, despite the potential for different divergent viruses to spread, surprisingly few viruses successfully expanded to cause the global epidemic. In approximately 80% of cases, productive infection is the result of infection with only a single virus or single virus-infected cell. After transmission, HIV evolves at a rapid rate driven by the immune pressure until the virus reaches a delicate survival balance: on one hand avoiding elimination through the development of cytotoxic T-cell immune escape mutations, and on the other sacrificing replication fitness as these mutations may come with a severe fitness cost to the virus. People infected with these 'attenuated' cytotoxic T-cell escape viruses can have a survival advantage. Cytotoxic T-cell responses are molding HIV diversity at a population level resulting in a loss of some of the common immune epitopes. SUMMARY: Insights into the origin of HIV and its evolution between populations and within individuals is essential to understanding HIV pathogenesis and imperative for the design of effective biomedical interventions such as vaccines.
Authors: Kevin K Ariën; Ryan M Troyer; Youssef Gali; Robert L Colebunders; Eric J Arts; Guido Vanham Journal: AIDS Date: 2005-10-14 Impact factor: 4.177
Authors: S M Wolinsky; C M Wike; B T Korber; C Hutto; W P Parks; L L Rosenblum; K J Kunstman; M R Furtado; J L Muñoz Journal: Science Date: 1992-02-28 Impact factor: 47.728
Authors: Kimberly Ritola; Christopher D Pilcher; Susan A Fiscus; Noah G Hoffman; Julie A E Nelson; Kathryn M Kitrinos; Charles B Hicks; Joseph J Eron; Ronald Swanstrom Journal: J Virol Date: 2004-10 Impact factor: 5.103
Authors: Manish Sagar; Ludo Lavreys; Jared M Baeten; Barbra A Richardson; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Joan K Kreiss; Julie Overbaugh Journal: AIDS Date: 2004-03-05 Impact factor: 4.177
Authors: Geoffrey S Gottlieb; David C Nickle; Mark A Jensen; Kim G Wong; Jandre Grobler; Fusheng Li; Shan-Lu Liu; Cecilia Rademeyer; Gerald H Learn; Salim S Abdool Karim; Carolyn Williamson; Lawrence Corey; Joseph B Margolick; James I Mullins Journal: Lancet Date: 2004-02-21 Impact factor: 79.321
Authors: Brandon F Keele; Hui Li; Gerald H Learn; Peter Hraber; Elena E Giorgi; Truman Grayson; Chuanxi Sun; Yalu Chen; Wendy W Yeh; Norman L Letvin; John R Mascola; Gary J Nabel; Barton F Haynes; Tanmoy Bhattacharya; Alan S Perelson; Bette T Korber; Beatrice H Hahn; George M Shaw Journal: J Exp Med Date: 2009-05-04 Impact factor: 14.307
Authors: Glenda E Gray; Mary Allen; Zoe Moodie; Gavin Churchyard; Linda-Gail Bekker; Maphoshane Nchabeleng; Koleka Mlisana; Barbara Metch; Guy de Bruyn; Mary H Latka; Surita Roux; Matsontso Mathebula; Nivashnee Naicker; Constance Ducar; Donald K Carter; Adrien Puren; Niles Eaton; M Julie McElrath; Michael Robertson; Lawrence Corey; James G Kublin Journal: Lancet Infect Dis Date: 2011-05-11 Impact factor: 25.071
Authors: Elena Dukhovlinova; Alexey Masharsky; Olga Toussova; Sergei Verevochkin; Tatiana Solovyeva; Maria Meringof; Elijah Paintsil; Edward White; Russell Barbour; Robert Heimer; Andrei Kozlov Journal: AIDS Res Hum Retroviruses Date: 2015-01-05 Impact factor: 2.205
Authors: Hong Na; Shaona Acharjee; Gareth Jones; Pornpun Vivithanaporn; Farshid Noorbakhsh; Nicola McFarlane; Ferdinand Maingat; Klaus Ballanyi; Carlos A Pardo; Eric A Cohen; Christopher Power Journal: Retrovirology Date: 2011-06-06 Impact factor: 4.602
Authors: Niamh M Keane; Steven G Roberts; Coral-Ann M Almeida; Tanya Krishnan; Abha Chopra; Emma Demaine; Rebecca Laird; Monika Tschochner; Jonathan M Carlson; Simon Mallal; David Heckerman; Ian James; Mina John Journal: Immunol Cell Biol Date: 2011-05-17 Impact factor: 5.126